Table 2.
Ocular Characteristics at Baseline and F/U
| NPDR | PDR | |
|---|---|---|
| No. of eyes | 98 | 97 |
| Laterality, OD | 48 (49.0) | 55 (56.7) |
| BCVA, Letters, baseline | 80 (74–84) | 78 (70–82) |
| IOP (mm Hg), baseline | 17.0 (14.0–19.0) | 17.0 (15.0–18.0) |
| DME, baseline, yes | 70 (71.4) | 59 (60.8) |
| Lens status | ||
| Phakia | 71 (72.4) | 58 (59.8) |
| Pseudophakia | 27 (27.6) | 39 (40.2) |
| Prior history of treatment | ||
| None | 71 (72.4) | 48 (49.5) |
| Injection | 26 (26.5) | 39 (40.2) |
| Focal laser | 3 (3.1) | 8 (8.2) |
| PRP | 0 | 12 (12.4) |
| PPV | 0 | 5 (5.2) |
| Treatment during F/U | ||
| None | 57 (57.2) | 42 (43.3) |
| Injection | 41 (41.8) | 47 (48.5) |
| Focal laser | 0 | 2 (2.1) |
| PRP | 2 (2.0) | 17 (17.5) |
| PPV | 0 | 0 |
| OCTA F/U time, months | 17.0 (12.0–27.0) | 15.0 (7.5–26.0) |
BCVA, best corrected visual acuity; DME, diabetic macular edema; F/U, follow-ups; PPV, pars plana vitrectomy.
Values are median (IQR) or number (%).